2023
DOI: 10.3390/pharmaceutics15030807
|View full text |Cite
|
Sign up to set email alerts
|

Chitosan-Based Biomaterials for Tissue Regeneration

Abstract: Chitosan is a chitin-derived biopolymer that has shown great potential for tissue regeneration and controlled drug delivery. It has numerous qualities that make it attractive for biomedical applications such as biocompatibility, low toxicity, broad-spectrum antimicrobial activity, and many others. Importantly, chitosan can be fabricated into a variety of structures including nanoparticles, scaffolds, hydrogels, and membranes, which can be tailored to deliver a desirable outcome. Composite chitosan-based biomat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 42 publications
(3 citation statements)
references
References 168 publications
0
3
0
Order By: Relevance
“…; 71 chitosan shows practical values in repairing defective bone, cartilage, skin, liver, vascular, and cardiac tissues. 72 When integrated into microfluidic systems, these biomaterials with in vivo -like physical and biochemical properties could effectively maintain the cell viability, facilitate structural organization, and recover the function of organ cells. 73 The difference in the progression from tissue engineering to organs-on-chips is the that size of biomaterials for tissue engineering should match with the studied tissues or organs, while the biomaterials for organs-on-chips are usually designed into microscale sizes to match the microfluidic chambers.…”
Section: Biomaterials In Tissue Engineering Vs Organs-on-chipsmentioning
confidence: 99%
“…; 71 chitosan shows practical values in repairing defective bone, cartilage, skin, liver, vascular, and cardiac tissues. 72 When integrated into microfluidic systems, these biomaterials with in vivo -like physical and biochemical properties could effectively maintain the cell viability, facilitate structural organization, and recover the function of organ cells. 73 The difference in the progression from tissue engineering to organs-on-chips is the that size of biomaterials for tissue engineering should match with the studied tissues or organs, while the biomaterials for organs-on-chips are usually designed into microscale sizes to match the microfluidic chambers.…”
Section: Biomaterials In Tissue Engineering Vs Organs-on-chipsmentioning
confidence: 99%
“…An ideal organoid matrix should possess high biocompatibility, good mechanical properties, degradability, and the ability to simulate the microenvironment to support and enhance cellular activities, such as proliferation, migration and differentiation [10]. To date, several natural and synthetic materials, including collagen [11], gelatin [12], polyethylene glycol [13], chitosan [14], and hyaluronic acid [15], have been used to generate organoids; these materials do not meet all of the requirements of the ideal organoid matrix [10]. A decellularized matrix retains the native tissue structure and provides an optimal microenvironment for cell survival, as well as a porous nanofiber scaffold that facilitates stem cell attachment, proliferation, and infiltration, while preserving the structural integrity of nanofibers [16].…”
Section: Introductionmentioning
confidence: 99%
“…In addition, chitosan has limited mechanical strength and needs chemical modifications to improve its characteristics. It appears that alginate-based biomaterials have several advantages over chitosan-based biomaterials owing to their high biocompatibility, ease of formation into hydrogels, adjustable degradation rate, and good mechanical features [ 43 , 44 ]. This review endeavored to elaborately discuss the current applications of alginate-based biomaterials in TE-RM, with a focus on recent advancements, important challenges, and future perspectives.…”
Section: Introductionmentioning
confidence: 99%